Title: |
Practice guide of drug monitoring and management for the treatment of inflammatory bowel disease in children in China(2023) |
Edition: |
Original |
Classification: |
Experts consensus |
Field: |
Diagnosis and Treatment |
Countries and regions: |
China |
Guidelines users: |
pediatrician |
Evidence classification method: |
德尔菲法 |
Development unit: |
Shengjing Hospital of China Medical University |
Registration time: |
2023-09-20 |
Registration number: |
PREPARE-2023CN403 |
Purpose of the guideline: |
To provide unified standards and standardized recommendations for the monitoring of therapeutic drugs for children with inflammatory bowel disease in China |